Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Column chromatography led to the isolation and full characterization of -cerotoyltryptamine () previously described in a mixture of 5 compounds, asimicin () and -19-Carbomethoxykauran-17-oic acid () isolated from this species for first time alongside stigmasterol glycoside () and lacceroic acid (). The structures of the compounds were established by extensive EIMS, HRESIMS, 1 D and 2 D NMR studies. Compound and the extract AS were more potent inhibitors of ROS with IC values of 2.7 ± 0.1 µg/mL and 8.7 ± 10.2 µg/mL respectively than Ibuprofen (11.2 ± 1.9 µg/mL) as a standard anti-inflammatory drug. Compound showed high inhibition on nitric oxide (IC = 3.9 ± 0.2 µg/mL), almost 6 times more active than the standard compound L-NMMA (IC = 24.2 ± 0.8 µg/mL) used. Compounds showed relatively low toxicity on NIH-3T3 fibroblast cells compared to standard. The results indicate that compounds and are potent anti-inflammatory drug candidates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14786419.2019.1634713 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!